Skip to content

Effect of dexamethasone combined with intercostal nerve block on postoperative pain and quality of recovery after thoracoscopic surgery

Effect of dexamethasone combined with intercostal nerve block on postoperative pain and quality of recovery after thoracoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097257
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-02-17
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodule

Interventions

Test group 1 (5mg dexamethasone group):Intercostal nerve block was given under direct thoracoscopic vision before chest closure. The block site was the surgical incision and the upper and lower interc
Experimental group 2 (10mg dexamethasone group):Intercostal nerve block was given under direct thoracoscopic vision before chest closure. The block site was the surgical incision and the upper and low

Sponsors

The affiliated yongchuan hospital of chongqing medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing single-port thoracoscopic lung surgery under general anesthesia at the elective stage 2. ASA grade I-III, 18~75 years old, body mass index (BMI) 18-28kg/m^2 3. Patients are aware of the content of the study and express their willingness to participate in and cooperate with the research work

Exclusion criteria

Exclusion criteria: 1. Patients with skin or deep tissue infection at the puncture site, patients with severe thoracic deformity 2. Patients with a history of allergy to local anesthetics and adrenocorticosteroids 3. Contraindications to dexamethasone (peptic ulcer, systemic infection, glaucoma, active varicella/herpes infection, diabetes mellitus with multiple complications) 4. Patients with coagulation dysfunction or receiving anticoagulant therapy 5. Patients with a history of neurological and psychiatric diseases or who are unable to use VAS to provide pain scores 6. Patients with hepatic and renal insufficiency 7. Patients with chronic opioid use 8. Patients admitted to ICU after surgery

Design outcomes

Primary

MeasureTime frame
Duration of analgesia;

Secondary

MeasureTime frame
QoR-15 score;Opioid consumption 24h/48h after surgery;VAS rest/cough pain score and hemodynamic parameters;Intraoperative opioid consumption and duration of surgery;Time of chest drainage tube removal and length of hospital stay;The incidence of postoperative complications (nausea and vomiting; Itching; Respiratory depression; Pneumothorax; Local hemorrhage and hematoma; Postoperative systemic or wound infection, injury Delayed healing of mouth);

Countries

China

Contacts

Public ContactMingqing Peng/Xiangwei Zhou

The affiliated yongchuan hospital of chongqing medical university

700459@hospital.cqmu.edu.cn+86 186 2310 4219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026